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Abstract 
In the review article the problems of modeling cerebral ischemia in small mammals 
are consecrated. The advantages of experimental studies that are based on the similarity of the 
blood circulation of the brain in humans and animals are indicated. Classification of 
experimental models for the study of acute and chronic disorders of cerebral circulation, 
mechanisms of their development and preclinical approbation of new drugs is given. The 
authors indicate that all experimental models of brain ischemia can be divided into two 
groups: to study risk factors and pathophysiological studies of brain ischemia. And in the 
second case, the models of focal and global ischemia are described. In conclusion, the authors 
point out the difficulties and shortcomings of certain methods of ischemia reproduction, 
which await researchers to solve the above problems. 





К ПРОБЛЕМАМ МОДЕЛИРОВАНИЯ ИШЕМИИ ГОЛОВНОГО МОЗГА  
У МЕЛКИХ ЖИВОТНЫХ 
 
А. Н. Стоянов, С. С. Мащенко, И. О. Остапенко, И. К. Бакуменко, С. М. Олейник,  
В. З. Скоробреха  
 
Одесский Национальный Медицинский Университет 
 
В обзорной статье освещены проблемы моделирования ишемии головного мозга 
у мелких млекопитающих. Показаны преимущества экспериментальных исследований, 
основанных на сходстве кровообращения головного мозга у человека и животных. Дана 
классификация экспериментальных моделей для изучения острых и хронических 
нарушений мозгового кровообращения, механизмов их развития и доклинической 
апробации новых лекарственных препаратов. Авторы указывают, что все 
экспериментальные модели ишемии головного мозга можно разделить на две группы: 
для изучения факторов риска и патофизиологических исследований ишемии головного 
мозга. Во втором случае описываются модели очаговой и глобальной ишемии. В 
заключение авторы указывают на трудности и недостатки некоторых методов 
воспроизводства ишемии, которые ждут исследователей для решения вышеуказанных 
проблем. 




Developed vascularization of the brain of higher vertebrates is an essential element for 
ensuring the functioning of the central nervous system. The scheme of such a blood supply in 
mammals implies the presence of four vascular pools. Angioarchitecture - as the order of 
branching and formation of the main and smaller arteries of the brain, the structure of their 
walls in rats has similarities with humans, as well as with many other animals. 
The vessels contain a pronounced endothelial lining with a developed cytoskeleton 
and the presence of tight contacts, which is necessary for adequate functioning and interaction 
of cells [1]. 
The formation of microcirculation is directly related to neurogenesis as a result of the 
working interaction of the nerve centers and the vascular capillary environment. 
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Structural and functional unit of the brain, as in humans is the so-called. module. The 
vascular network corresponds to the morphology and boundaries of the module and is 
surrounded by astrocytes, isolating the latter. At the same time, the density and distribution of 
blood vessels directly depend on the neuronal activity of the brain [2]. 
On the surface a well-developed basal membrane of cerebral arteries are located 
circularly located myocytes, then the adventitia is located forming the Virchow-Robin space, 
which is gradually replaced by astrocytes, which form the pericapillary case for the full 
operation of the blood-brain barrier. Endotheliocytes and pericytes provide the barrier 
functions of capillaries, regulate the diameter and movement of blood. Areas devoid of such a 
barrier, as in humans, contain thin-walled fenestrated capillaries in the area of the 
hypothalamus, the third and fourth ventricles. 
It should be noted that in conditions of circulatory disorders, secondary angiogenesis 
of cerebral tissue proceeds with the participation of humoral influences, a number of 
endothelial growth factors, especially fibroblasts, which are formed by glial, and possibly 
neuronal cells [3,4]. 
A large variety of small and large animals is used to model vascular pathology of the 
human brain. At the same time, publications on the comparative structural and topographical 
correlations, the structure of the arterial circle of the large brain, as well as the morphometry 
of vascular indicators in the available modern literature are not sufficiently represented. And 
for an adequate experimental cerebral-vascular damage in animals requires an objective and 
accurate extrapolation of the available data of this kind to humans. 
It is known that in a white rat a closed circle of Willis occurs in 75% of cases. The 
caliber of each internal carotid artery (ICA) is 1.2 times the diameter of the basilar artery, 
which adds up to 2.4 times the increase in blood flow. EI Bon, N. E. Maximovich (2018) [2] 
indicate that the main blood flow to the brain (up to 90%) is carried out by the ICA. In 
addition, in 50% of animals, the arterial circle of the large brain can appear as "8" as a result 
of closing the caudal connective vessels with an additional connecting artery. Keep in mind 
that a high hemoglobin content (16 g / 100 ml) is recorded in a rat [2]. So their inflow to the 
brain is predominantly via the ICA, which is natural for humans [5]. 
It should be borne in mind that in the experiment reproducibility of ischemia is not 
always achieved, this circumstance can be explained by the good development of the arteries 
of the Willis circle in rats and the severity of collateral blood flow. 
Nevertheless, the similarity of the sources of the structure and topography of the 
vascular system, the main hemodynamic parameters is a good reason to use data from the 
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simulation of vascular brain pathology in rats with further comparison with the human 
cerebral vascular pathology (CVP) [6, 7]. 
At the present stage of development of experimental neurology, a sufficient number of 
models have been developed, including for the study of acute and chronic vascular dysgemia, 
risk factors, mechanisms for their development of CVP, preclinical testing of new diagnostic 
and therapeutic techniques. 
Most of the models solve specific problems of studying regeneration processes, the 
severity of damage to the nervous system, testing various neurotropic, nootropic, vasoactive 
and other means, as well as treatment strategies with proven effectiveness. 
In this regard, the use of small animals is optimal [5-7], which is associated with the 
previously described features of the structure and functioning of the vascular system, the 
availability of measurement of basic physiological parameters of life, the size of animals 
reducing the cost of maintenance and nutrition, as well as high throughput during the 
experiment . In addition, consideration should be given to the possibility of genetic studies 
with a large choice of transgenic individuals that broaden the understanding of the specific 
development mechanisms of specific pathologies. Modern models are also aimed at studying 
the risk factors for cardiovascular diseases, the number of which exceeds 180, development 
and their correction, and therefore, prevention and prevention of the effects of brain 
catastrophes [8-11]. 
At the same time, an important direction for improving such models is to reduce the 
traumaticity, material costs, combined with humanity in relation to animals [12]. 
Currently, the experiment applies and improves complex methods of neuroimaging 
and functional diagnostics for small animals [13] including study of evoked potentials, 
encephalographic monitoring, composition of blood gases, blood pressure, etc. Moreover, as 
with large mammals, these measurements can be performed simultaneously at everyone 
animal. The convenience of observing sensory and motor behavior and the small size of the 
brain (for processing speed, biochemical, morphological and other analysis) can also be 
regarded as the advantage of working with small rodents [13]. 
Oxygen deficiency is a typical damaging process and the basis of many other 
pathological changes. 
There are hypoxia as a result of insufficient oxygen in the air, its entry into the body, 
transport to the cells, impairment of utilization. According to the mechanism of occurrence of 
hypoxic states, the following are distinguished: exogenous; Disturbance of oxygen supply or 
utilization - respiratory, circular, hemic, histological, mixed. A.Z.Kolchinskaya (1981) [14] 
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classified hypoxic hypoxia with a decrease in the partial pressure of oxygen, hyperoxic, 
hypobaric with an increase in the total barometric pressure and hypoxia of the load. 
 Experimental models of hypoxia imply fixation of animal lifetimes, behavior, and 
loss of pose. The simplest technique is to place the rat in a hermetic glass jar corresponding to 
the mass of the animal. There is arterial hypoxemia, a decrease in oxygen consumption in the 
blood plasma and a decrease in hemoglobin saturation. The introduction of sodium nitrite 
causes hemic hypoxia with the formation of carboxyhemoglobin. Hypobaric hypoxia is 
studied in a flow-exhaust pressure chamber with the "rise" of an animal at a speed of 25-50 m 
/ s to a height of 8-11 thousand meters [15]. 
 Priorities remain for researchers in terms of approaching ischemia models to the 
corresponding clinical task. However, difficulties arise due to the heterogeneity of the 
etiopathogenetic factors causing ischemic stroke, as well as the clinical variability associated 
with the continuation, localization, severity of ischemia, and the presence of comorbid 
systemic diseases. A large block of models examines specific risk factors for ischemia and 
other disorders directly correlated with stroke, which is an important aspect of the reliability 
of obtaining results. 
Dietary approaches are traditionally used in models of atherosclerosis. Other risk 
factors that alter the work of endothelial cells with the reaction of vascular wall remodeling 
are also taken into account [16]. Genetic models of small rodents with the activity of the 
ApoE gene, other genetic models of hypercholesterolemia (mice with Apolipoprotein B), as 
well as other transgenic animals are used to study lipid metabolism and accelerated 
atherosclerosis [17-27]. 
Histomorphological analysis and the developing pathological process is similar to 
atherosclerotic damage to human vessels. However, mice do not experience spontaneous 
thrombotic and embolic total occlusions. 
Experimental models of arterial hypertension as the most important risk factor for 
strokes have been developed. Nabika T. et al. indicate that the advantages of this type of 
model exclude genetic heterogeneity, environmental interference, statistical uncertainty due to 
possible small groups of patients. [28]. Wistar rats were obtained with an increased pressure 
of up to 180-200 mmHg. By the 17th week of life, at the same time, despite the clinic, serious 
problems in the form of ischemic stroke (IS) rarely develop. Animals with the activity of 
genes involved in vasoreactivity that alter NO function with a reliable development of IS for 
9–13 months have been derived [29,30]. 
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Not always the exact mechanism of the development of arterial hypertension is clear 
even in the presence of a known gene in transgenic rats. Experimental models of an important 
factor of an atherothrombosis strengthening - a hyperhomocysteinemia are used. The 
concentration of plasma homocysteine can be increased tenfold. This can be achieved by 
disrupting the CBS gene, cystathionine beta-synthase, as well as in mice with a deficiency of 
a specific oxidooctase encoded by the gene [31]. 
To study the mechanisms of aging as the main factor in the development of AI, mice 
of the OXYS line associated with a genetic increase in sensitivity to oxidative stress were 
bred. Transgenic mice are used as a model of CADASIL small vessel disease. 
Oxidative stress is a universal pathophysiological process that occurs during ischemic 
damage to the central nervous system [34]. Experimental models of IS are known using 
indicators of metabolism in free-radical lipid oxidation (LPO) [32]. In rats, the maximum 
number of active metabolites of was determined in the first hours of the experiment [33-35]. 
In another series of experiments aimed at reperfusion of the brain after vascular ischemia, 
there is an even greater risk of re-oxygenation of neurons with an "explosion" of the synthesis 
of reactive oxygen species, with the development of oxidative stress [32,36]. 
The literature data confirm the leading role of the intensification of lipid peroxidation 
processes in the development of neurodegenerative states [37–39]. 
Toxicity, induced hyperactivation of the neurotransmitter system of excitatory amino 
acids, damage to cell membranes and mitochondria, intensification of lipid peroxidation 
processes, hypersecretion of proinflammatory cytokines and growth factors, inflammation, 
apoptosis are often considered as potential targets for the development of therapeutic effect 
[33]. 
An important area of experimental models of cerebral ischemia is the study of 
impaired functioning of neurotransmission. In this case, the main role is assigned to 
glutamate, the release of which leads to "death from arousal" [40-43]. A closed pathological 
circle is formed, in which a cascade of interconnected pathological reactions with ischemic 
neuronal damage, increased production of excitatory neurotransmitters, a deficiency of high 
energy substances, accumulation of free calcium, nitric oxide, proinflammatory cytokines, 
endogenous cannabinoids and other substances increased severity of lipid peroxidation 
processes [44]. 
From the above it follows that the experimental models can be divided into two 
groups: 
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1. Models of studying risk factors for ischemic neurons that provoke damage to 
cerebral vessels, as well as preventive correction. 
2. Models of pathophysiological study of chronic cerebral ischemia, AI, transient 
ischemic attacks, as well as for testing the therapeutic possibilities of drugs (neuroprotection, 
neuroplasticity, regeneration, recanalization, etc.). 
In turn, the second point of the consequences of acute and chronic ischemia is further 
divided into two blocks of models: 
a) focal (focal, regional) ischemia "as a stroke"; 
b) global ischemia of the "cardiac arrest" type. 
To create models of focal ischemia in rodents, occlusions are used in the form of 
arterial ligation: 
The method of Pulsinelli W. A. models temporal ischemia by ligation of the common 
carotid arteries (CCA) and the external carotid artery with additional ligation of the vertebral 
artery (VA) [45]. 
Method Koizumi J. - by ligation of the right common carotid and external carotid 
arteries, followed by the introduction of the occluder through bifurcation of the CCA into the 
internal carotid to the middle cerebral artery and fixation of the occluder by ligation of the 
ICA [46]. 
Sufianov G.Z. Method et al. uses carotid occlusion - ligation of the common and 
external carotid artery and the introduction of the occluder through the common carotid artery 
and then into the ICA and ligated the OCA of the opposite side [47]. 
The method of Pulsinelli W. A. [45] modified by Mitsuo Yamaguchi et al. [48] 
consists in a one-step anterior approach with four vessels occlusion (4VO). 
Tamura et al. (1981) suggested occlusion of the MCA in the proximal segment using 
subtemporal craniotomy [49-51]. 
In addition to ligation of the arteries is used: 
Thermo-, electrocoagulation in order to burn through the middle cerebral artery 
(MCA) [52]. 
Endothelin-1-induced narrowing of the arteries. A method for the combined use of 
endothelin and occlusion of CCA has been developed. 
Introduction of microfilaments leaving or in a temporary interval removing suture 
material, causing reperfusion. 
The use of a thread in the vessel lumen in the form of a 4-0 nylon suture insert, and 
then selecting the thickness of the thread blocking the vessel lumen [53-55]. 
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Modeling of the occlusion using the CCA filament according to the J. Koidzumi 
method with doppler examination allows to control the degree and stability of the occlusion 
and exclude animals with atypical cerebral blood flow from the experiment. 
Vascular embolization with synthetic macrospheres induces large foci of ischemia, 
microspheres up to 50 microns - multifocal infarctions. [56]. 
Occlusion of the VSA with autologous blood clot is used to study thrombolytic and 
reperfusion therapy. 
For photoinduced vascular thrombosis, IV injection of the photosensitizer is 
performed. And for irradiation using an argon laser or visible light. Water-soluble xanthene 
dyes are used as a photosensitizer, including rose bengal with an induction λ of 560 nm. [36]. 
In modern models of cerebral ischemia, an introduction to various vessels is also used: 
cobra venom; human atherosclerotic masses from the aorta; platelet aggregates (a mixture of 
platelets and white blood cells); and laser coagulation of the arteries [36]. 
In models of global ischemia, the CNS uses a complete and incomplete arrest of 
blood circulation in the brain. 
Intracardiac administration of an aqueous solution of potassium chloride is used as a 
complete ischemia, which inhibits the contractility and myocardial excitability [57]; 
Decapitation to study the mechanisms of the work of fast-acting drugs, biochemical 
studies [60]; 
Placing a harness (cervical turnstile) or cuff on the neck [58-59], the technique is 
effective for studying pathological processes in the hippocampus and trunk [60]; 
Compression of the chest of the animal based on the method of modeling clinical 
death - Patent of Ukraine No. 28969. Then, cardiopulmonary resuscitation was carried out 
[61,62]; 
Simulation of heart failure by retrosternal clipping of vessels over the heart. Complete 
ligation / compression of all arteries extending from the heart [63]. 
Induction of ventricular fibrillation to simulate cardiac arrest; 
Lowering blood pressure (bloodletting) or exsanguination of the animal, followed by 
recovery; 
Ligation of the common carotid and subclavian arteries distal to the discharge of the 
internal thoracic arteries and proximal to the separation of the VA according to the 
Rozvadovsky method [64]; 
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M.P. Plotnikov et al. (2015) [65] used two surgical access to the left CCA, the 
brachiocephalic stem and the left subclavian artery. The operation was carried out bypassing 
the pleural cavity to exclude complications, pneumothorax. 
Among small rodents in terms of developing a model of ischemic brain damage, there 
is a gerbil, which in vascular anatomy has no connections between the main brain basins 
(carotid and vertebrobasilar). Global ischemia can be caused by bilateral occlusion of the 
carotid artery. At the same time, technical implementation is much easier than in rats [56]. 
Unilateral occlusion of the carotid artery also causes damage in the form of unilateral 
infarction with severe neurological symptoms in 30-40% of cases. 
Models of incomplete global ischemia are intermediate between focal and global 
ischemia. These include: 
"Model by Rice" or "Rice-Vannucci" hypoxic ischemia by permanent occlusion of one 
CCA and subsequent placement into the atmosphere with low (no more than 8%) oxygen 
content. A variant is the bilateral occlusion of two CCA. Occlusion of two or only the right 
CCA, followed by a decrease in atmospheric pressure in the pressure chamber to 277 mm Hg. 
Art. with an exposure of 90 minutes, it allows to study hypoxic hypoxia [56]. 
Variant of two-vascular occlusion of CCA and hypotension (including controlled drug 
hypotension or bleeding) Onken M. et al., 2012. In these experiments elements of hypoxia 
and ischemia are combined. 
The bilateral occlusion of two CCA by the method of Eklof and Siesjo (1972) is 
widely used to study the energy state of the brain after incomplete ischemia (Smith et al., 
1984) [66]. 
In conclusion, it should be noted that among the diversity of experimental models that 
solve the problem of studying the vascular pathology of the brain there are certain difficulties. 
Low reproducibility of ischemic damage to the central nervous system, due to the anatomical 
difference in the structure of the arterial circle of the large brain - in half of the cases there is 
an additional connective artery and pronounced collateral blood flow. 
Inaccuracy of ischemia reproduction in a specific region of the brain with a number of 
focal models of cerebral circulation disorders. 
The complexity of surgical access to certain arteries of the respective basin implies the 
need for special skills from the researcher. Aggressiveness of the so-called. "phased" methods 
of occlusion of several arteries, which is significantly different from the actual conditions for 
the development of stroke. 
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The use of various occluders contributes to trauma, perforation of the vessel with 
possible postoperative complications. The need for special equipment, optical instruments, a 
microscope, microsurgical equipment, laser or photo-optical installations, a pressure chamber, 
a thermocoagulator, microfilaments with various coatings on the intravascular part, devices 
for inducing ventricular fibrillation, etc. 
The variety of anesthetic methods and tools and their combinations can also negatively 
affect the data obtained. The same circumstances apply to complex diagnostic equipment of 
various modifications for the study of evoked potentials, brain bioelectrogenesis, blood 
circulation velocity, vascular resistance, modern neuroimaging methods, etc. As well as the 
use of special laboratory equipment and reagents, which makes it difficult to compare and 
interpret data when using various technical devices. 
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